Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 323

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

PD‐L1 expression on tolerogenic APCs is controlled by STAT‐3

Open access
Wölfle, Sabine J., Strebovsky, Julia, Bartz, Holger, Sähr, Aline, Arnold, Caroline, Kaiser, Claus, Dalpke, Alexander H., Heeg, Klaus·2011·European Journal of Immunology

Abstract

During infection, TLR agonists are released and trigger mature as well as differentiating innate immune cells. Early encounter with TLR agonists (R848; LPS) blocks conventional differentiation of CD14+ monocytes into immature dendritic cells (iDCs) resulting in a deviated phenotype. We and others characterized these APCs (TLR‐APC) by a retained expression of CD14 and a lack of CD1a. Here, we show in addition, expression of programmed death ligand‐1 (PD‐L1). TLR‐APCs failed to induce T‐cell proliferation and furthermore were able to induce CD25+Foxp3+ T regulatory cells (Tregs). Since PD‐L1 is described as a key negative regulator and inducer of tolerance, we further analyzed its regulation. PD‐L1 expression was regulated in a MAPK/cytokine/STAT‐3‐dependent manner: high levels of IL‐6 and IL‐10 that signal via STAT‐3 were produced by TLR‐APCs. Blocking of STAT‐3 activation prevented PD‐L1 expression. Moreover, chromatin immunoprecipitation revealed direct binding of STAT‐3 to the PD‐L1 promoter. Those findings indicate a pivotal role of STAT‐3 in regulating PD‐L1 expression. MAPKs were indirectly engaged, as blocking of p38 and p44/42 MAPKs decreased IL‐6 and IL‐10 thus reducing STAT‐3 activation and subsequent PD‐L1 expression. Hence, during DC differentiation TLR agonists induce a STAT‐3‐mediated expression of PD‐L1 and favor the development of tolerogenic APCs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/eji.201040979

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 50 references

Cited by

See all 323

Metadata

Authors
Wölfle, S. J., Strebovsky, J., Bartz, H., Sähr, A., Arnold, C., Kaiser, C., Dalpke, A. H., & Heeg, K.
Venue
European Journal of Immunology
Publisher
Wiley
Published
2011-01-11
Volume
41
Issue
2
Pages
413-424
ISSN
  • 0014-2980 (ISSN-L)
  • 1521-4141
OpenAlex
W2053782627
Cited by
323
References
50
FWCI
6.21
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: PD‐L1 expression on tolerogenic APCs is controlled by STAT‐3. https://app.cochat.ai/papers/10.1002/eji.201040979
The paper
Wölfle, S. J., Strebovsky, J., Bartz, H., Sähr, A., Arnold, C., Kaiser, C., Dalpke, A. H., & Heeg, K. (2011). PD‐L1 expression on tolerogenic APCs is controlled by STAT‐3. European Journal of Immunology. https://doi.org/10.1002/eji.201040979

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.